Department of Urology, Keio University School of Medicine, Tokyo, Japan.
Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Clin Endocrinol (Oxf). 2021 Nov;95(5):716-726. doi: 10.1111/cen.14557. Epub 2021 Jul 19.
Pheochromocytoma is a rare neuroendocrine tumour that secretes catecholamines and originates in the adrenal gland. Although surgical resection is the only curative therapy for pheochromocytoma, it is associated with a risk of haemodynamic instability (HDI), such as extremely high blood pressure and/or post tumour removal hypotension and shock. We investigated the risk factors for HDI during pheochromocytoma surgery.
Eighty-two patients who underwent laparoscopic adrenalectomy for pheochromocytoma between July 2002 and February 2020 were examined. We excluded 3 patients with bilateral disease and 11 without detailed 24 h urinary data. We defined HDI as systolic blood pressure ≥ 200 or <80 mmHg. We investigated the risk factors for HDI during laparoscopic adrenalectomy for pheochromocytoma.
There were 29 males and 39 females with a median age of 50.5 years. Tumours were localised on the right adrenal gland in 28 patients and on the left in 40. The median tumour diameter was 37.5 mm and the median pneumoperitoneum time was 93.5 min. Twenty-five out of sixty-eight patients (37%) developed HDI. A multivariate analysis identified diabetes mellitus (DM; odds ratio: 3.834; 95% confidence interval: 1.062-13.83; p = .04) as an independent predictor of HDI. In terms of hormonal data, median 24 h urinary epinephrine levels (p = .04) and metanephrine levels (p = .01) were significantly higher in the HDI group. DM was also considered as a risk factor for prolonged HDI (p = .02).
Surgeons and anaesthesiologists need to be aware of the risk of HDI and its prolongation during laparoscopic adrenalectomy for pheochromocytoma for DM patients.
嗜铬细胞瘤是一种罕见的神经内分泌肿瘤,分泌儿茶酚胺,起源于肾上腺。虽然手术切除是嗜铬细胞瘤的唯一治愈性治疗方法,但它与血流动力学不稳定(HDI)的风险相关,如极高的血压和/或肿瘤切除后的低血压和休克。我们研究了嗜铬细胞瘤手术中发生 HDI 的危险因素。
对 2002 年 7 月至 2020 年 2 月间接受腹腔镜肾上腺切除术治疗的 82 例嗜铬细胞瘤患者进行了检查。我们排除了 3 例双侧疾病患者和 11 例无详细 24 小时尿数据的患者。我们将 HDI 定义为收缩压≥200 或<80mmHg。我们研究了腹腔镜肾上腺切除术治疗嗜铬细胞瘤中发生 HDI 的危险因素。
患者中有 29 名男性和 39 名女性,中位年龄为 50.5 岁。肿瘤位于右侧肾上腺 28 例,左侧 40 例。肿瘤直径中位数为 37.5mm,气腹时间中位数为 93.5 分钟。68 例患者中有 25 例(37%)发生了 HDI。多变量分析发现糖尿病(DM;比值比:3.834;95%置信区间:1.062-13.83;p=0.04)是 HDI 的独立预测因素。就激素数据而言,HD 组的 24 小时尿肾上腺素水平(p=0.04)和变肾上腺素水平(p=0.01)中位数明显较高。DM 也被认为是 HDI 延长的危险因素(p=0.02)。
外科医生和麻醉师需要意识到 DM 患者在腹腔镜肾上腺切除术治疗嗜铬细胞瘤时发生 HDI 及其延长的风险。